David Geffen School of Medicine at UCLA NICHD CRS (5112) — Los Angeles, California

David Geffen School of Medicine at UCLA NICHD CRS (5112) is a clinical research site located in Los Angeles, California, United States 90095-1752.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

David Geffen School of Medicine at UCLA NICHD CRS (5112) has participated in 1 clinical trials.

Therapeutic areas: HIV-1 Infection.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for David Geffen School of Medicine at UCLA NICHD CRS (5112)?

David Geffen School of Medicine at UCLA NICHD CRS (5112) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has David Geffen School of Medicine at UCLA NICHD CRS (5112) conducted?

David Geffen School of Medicine at UCLA NICHD CRS (5112) has 1 clinical trials on record. Their work covers HIV-1 Infection.

Is David Geffen School of Medicine at UCLA NICHD CRS (5112) accredited by Crixeo Health?

David Geffen School of Medicine at UCLA NICHD CRS (5112) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about David Geffen School of Medicine at UCLA NICHD CRS (5112)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.